Intranasal Scopolamine
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
140
NCT04947423
Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion
Phase: Phase 3
Role: Collaborator
Start: Jun 14, 2021
Completion: Aug 12, 2021
Loading map...